Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6509353B1 · kind B1 · utility
1Cited by
15References
37Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 28, 2000 |
| Grant date | Jan 21, 2003 |
| Priority date | — |
| Expiry date | Feb 14, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and pharmaceutical compositions employing a terfenadine metabolite and a leukotriene inhibitor for the treatment or prevention of inflammation or allergic disorders, such as asthma, or symptoms thereof. Also included are methods and compositions employing a terfenadine metabolite, a leukotriene inhibitor, and a decongestant for the treatment or prevention of inflammation or allergic disorders, such as asthma, or symptoms thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.